invest forward pbc

NYS Entity Status
INACTIVE

NYS Filing Date
MAY 13, 2014

NYS DOS ID#
4576257

County

Jurisdiction

Registered Agent
NONE

NYS Entity Type
FOREIGN BUSINESS CORPORATION RESERVATION

Name History
2014 - INVEST FORWARD PBC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • A Dip in the Living Room Pool
    Friday Sep 15, 2017

    In a slowing luxury real estate market, developers are investing in amenities to attract buyers. Explore Soori High Line, where more than half of the units come with private, saltwater pools.

    Source: NYT > Home Page
  • Steve Case’s Rise of the Rest Shines Spotlight on Emerging Tech Hubs
    By Sarah Schmid Stevenson - Monday Oct 9, 2017

    Steve Case, venture capitalist, author, and co-founder of AOL, is preparing to hit the road this week on his sixth Rise of the Rest tour, where he travels to emerging innovation hubs in search of investment-worthy tech startups and to highlight the growth happening outside of places like Silicon Valley and Boston. In the years […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Google.org, BlackRock, Others Commit $2.2M to Fast Forward’s Nonprofit Tech Accelerator
    By Staff Writer - Thursday Jul 13, 2017

    As impact investing gains traction in the market, a new accelerator for tech nonprofits called Fast Forward has raised $2.2 million in philanthropic funding from the nonprofit arms of some of the world’s largest companies and financial services firms. BlackRock, Google.org, Comcast NBCUniversal and AT&T joined Zendesk, Twilio.org, Hewlett Packard Enterprise, the Nasiri and Rita Allen Foundations […]

    The post Google.org, BlackRock, Others Commit $2.2M to Fast Forward’s Nonprofit Tech Accelerator appeared first on NonProfit PRO.

    Source: NonProfitPRO
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed